Keywords: trials, irinotecan, colorectal, cancer, suspended, safety, concerns

Two trials of irinotecan in colorectal cancer suspended on safety concerns

Article | 18 May 2001

Print This

Two US clinical trials of the topoisomerase I inhibitor irinotecan,which is marketed in that country as Camptosar by Pharmacia, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in